{"nct_id":"NCT01137994","title":"A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer","status":"WITHDRAWN","status_verified_date":"2013-03","start_date":"2011-10","start_date_type":null,"primary_completion_date":"2016-12","primary_completion_date_type":"ESTIMATED","completion_date":"2018-03","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}